|
ON THIS PAGE:
What
are ESAs
When to Use ESAs
Types of
ESAs
Commonly Used ESAs
(Aranesp, Epogen, Procrit, Eprex)
Obtaining
ESAs at Reasonable Prices
Dosage and Usage Guidelines
The Downsides of ESAs
Should I Use an
ESA
HOME
Site Overview
What You Need to Know
First
Alphabetical Index
Glossary
Research
Participation Opportunities
WHAT IS
CKD?
What Happens in
CKD?
Causes of CKD
Early Detection
How Bad is It?
Is There Any
Hope?
Acute Renal
Failure
KEY ISSUES
Nausea, Vomiting,
Appetite Loss and Excess Stomach Acid
Maintaining Hydration
The Importance of
Phosphorus Control
All About
Hypertension
All About
Anaemia
All About Constipation
Potassium Imbalances
Metabolic Acidosis
Kidney Stones
SUPPORT
Coping with CKD
Tanya's Support Group
Success Stories
SYMPTOMS
Alphabetical List of Symptoms and Treatments
Fluid
and Urinary Imbalances (Dehydration, Overhydration and Urinary
Issues)
Waste Product Regulation Imbalances (Vomiting, Appetite Loss, Excess
Stomach Acid, Gastro-intestinal Problems, Mouth Ulcers Etc.)
Phosphorus and Calcium Imbalances
Miscellaneous Symptoms
(Pain, Hiding Etc.)
DIAGNOSIS:
WHAT DO ALL THE TEST RESULTS MEAN?
Blood Chemistry: Kidney Function, Potassium, Other Tests
(ALT, Amylase, (Cholesterol, Etc.)
Complete Blood Count (CBC):
Red and White Blood Cells: Anaemia and Infection
Urinalysis (Urine Tests)
Other Tests: Ultrasound, Biopsy, X-rays etc.
Renomegaly (Enlarged Kidneys)
Which
Tests to Have and Frequency of Testing
Factors that Affect Test Results
Normal Ranges
International and US Measuring Systems
TREATMENTS
Which Treatments are Essential
Finding a Good Vet and Record Keeping
Fluid and Urinary Issues (Fluid Retention, Infections, Incontinence,
Proteinuria)
Waste Product Regulation
(Mouth Ulcers, GI Bleeding,
Antioxidants,
Adsorbents, Azodyl, Astro's CRF Oil)
Phosphorus, Calcium and PTH (Calcitriol)
Miscellaneous Treatments: Stem Cell
Transplants, ACE Inhibitors - Fortekor, Steroids, Kidney Transplants)
Antibiotics and Painkillers
Holistic Treatments (Including Slippery Elm Bark)
ESAs (Aranesp, Epogen etc.) for Severe Anaemia
General Health Issues in a CKD Cat: Fleas, Arthritis, Dementia,
Vaccinations
Tips on
Medicating Your Cat
Obtaining Supplies Cheaply in the UK, USA and Canada
Working with Your Vet
DIET & NUTRITION
Nutritional Requirements of CKD Cats
The B Vitamins (Including
Methylcobalamin)
What to Feed (and What to Avoid)
Persuading Your Cat to Eat
Food Data Tables
USA
Canned Food Data
USA
Dry Food Data
USA
Cat Food Manufacturers
UK
Canned Food Data
UK
Dry Food Data
UK Cat Food Manufacturers
2007 Food Recall USA
FLUID THERAPY
Intravenous Fluids
Subcutaneous Fluids
Tips on Giving
Subcutaneous Fluids
How
to Give Subcutaneous Fluids with a Giving Set
How
to Give Subcutaneous Fluids with a Syringe
Subcutaneous Fluids - Winning Your Vet's Support
Dialysis
RELATED DISEASES
Heart Problems
Hyperthyroidism
Diabetes
Polycystic Kidney Disease (PKD)
Pancreatitis
Dental Problems
Anaesthesia
OBTAINING SUPPLIES CHEAPLY
UK
USA
Canada
SAYING GOODBYE
Saying Goodbye
The
Final Hours
Coping with Your Loss
Other People's Losses
MISCELLANEOUS
Prevention
Research
Canine Renal
Failure
Other Illnesses (Cancer, Liver) and
Behavioural Problems
Diese Webseite auf Deutsch
SITEOWNER (HELEN)
My
Three CKD Cats: Tanya, Thomas and Ollie
My Multi Ailment Cat,
Harpsie
Find
Me on Facebook
Follow Me on
Twitter
Contact Me
|
|
Home >
Treatments
> Erythropoiesis
Stimulating Agents
Overview
-
Anaemia means that not enough red blood
cells exist in the body. It is relatively common in CKD cats,
so it is important to know about it and to be prepared to deal with it.
-
Treating anaemia in a CKD cat is worthwhile:
University of Georgia College of Veterinary Medicine
states that "anemia is not a poor prognostic indicator in cats as most
live for more than 300 days despite presenting with anemia."
-
Mild or moderate anaemia may be controlled using
various treatments which are discussed on the
Anaemia page. This page deals with a form of treatment for
severe non-generative anaemia called erythropoiesis stimulating agents, or ESAs.
What are Erythropoiesis Stimulating Agents
The kidneys produce a hormone called
erythropoietin which stimulates the bone marrow to make red blood cells. As the
kidneys fail in CKD, they cannot produce enough erythropoietin, so the
bone marrow is not stimulated, blood cells are not produced, and a
particular type of anaemia called non-regenerative anaemia results.
Non-regenerative anaemia may have other causes, but this is the most
common reason for it in CKD cats.
In addition, a uraemic toxin called
parathyroid hormone, which is not processed properly by damaged
kidneys, may also adversely affect the production of erythropoietin.
Cats with mild anaemia will be offered various treatments (see
the
Anaemia page). However, cats with severe non-regenerative anaemia
(PCV or HCT below 20%) caused by CKD often
need artifical erythropoietin in order to control their anaemia. The
various forms of artificial erythropoietin are collectively known as erythropoiesis stimulating agents (ESAs). They are usually very effective,
and in fact one human study,
Anemia management and the delay of chronic renal
failure progression (2003)
Rossert J, Fouqueray B & Boffa JJ Journal of
the American Society of Nephrology 14
pp173-177 found that "treatment with epoetin may slow the
progression of chronic kidney disease."
Unfortunately after a
few months of use a small percentage of cats may develop a reaction to
ESAs, commonly referred to on CKD support groups as the
antibody reaction,
which stops them working.
When to Use Erythropoiesis
Stimulating Agents
Some vets seem to rush to use ESAs as soon as a cat is diagnosed with
anaemia. Others seem to be terrified to use them because of the risk of an
antibody reaction
developing a few months after starting ESAs. Depending upon the severity,
type and cause of the anaemia, there are other treatments which may be
more appropriate and which are certainly cheaper. See the
Anaemia page for more information.
The basic criteria for using ESAs are as follows:
-
The PCV or HCT (a measurement of anaemia) will be between 15% and 19%, or
even lower, and the cat will be showing signs of anaemia, such as
breathlessness, lethargy or severe loss of appetite.
Managing anemia in patients with chronic kidney
disease (2011) Chalhoub S, Langston CE Veterinary Medicine
May 2011 mentions that the Animal Medical Center in NYC considers a
PCV below 20% to be the level at which treatment with an ESA should be considered.
-
The cat should have non-regenerative anaemia rather than regenerative
anaemia. A reticulocyte test can confirm this, although this test is only
accurate if the PCV or HCT has been below 20% for five days or longer.
-
The PCV or HCT should not have fallen suddenly, e.g.
from 24% one week to 17% the next. Most
cats with anaemia caused by CKD become anaemic gradually which means their
bodies have had time to adapt to it to a certain extent. Cats who develop
sudden, severe anaemia should be checked for
other causes, such as
gastro-intestinal bleeding.
-
Usually (but not always, particularly in older cats) the CKD will be relatively advanced, with creatinine over 5, at least at initial diagnosis. This indicates that the
kidney damage is probably more severe, and therefore the kidneys are
unlikely to be producing sufficient erythropoietin on their own.
Types of Erythropoiesis
Stimulating Agents
There are two categories of ESA which have been used in CKD cats:
Human
erythropoietin (rhEpo - Epogen, Procrit, Eprex,
NeoRecormon and Aranesp)
There has also been a study into the feline erythropoetin gene, and
another will be commencing shortly at the University of California at Davis.
Unfortunately, neither feline erythropoietin nor the feline erythropoietin
gene are commercially available at present (October 2011). I do discuss
below the current
situation regarding research into these treatments, but this page focuses
primarily on the treatments which are currently available for you to use, in
the form of human erythropoietin.
Human Erythropoietin
(ESAs)
Since feline erythropoietin is not
commercially available, most people whose cats need erythropoietin
supplementation will have to use human
erythropoietin. It takes the place of the cat's natural erythropoietin and
enables the bone marrow to continue to make red blood cells.
There are a number of different types of
human erythropoietin, as outlined in the table below. Although these
products all have the same goal, technically they are not exactly the
same, so they are referred to collectively as erythropoiesis
stimulating agents (ESAs).
Epogen, Eprex or Procrit (epoetin alfa)
These are all types of the epoetin alfa variant of recombinant human
erythropoietin:
-
Epogen, made and sold by Amgen, is the synthetic
version of epoetin alfa used in the USA for the
treatment of anaemia in human CKD patients on dialysis.
-
Procrit is the
same product, epoetin alfa, made by Amgen but sold by Ortho Biotech in the
USA for the treatment of anaemia in human CKD patients who are not on
dialysis. It is also
commonly used for cancer patients with anaemia caused by chemotherapy.
-
Eprex
is the version of epoetin alfa made
by Janssen-Cilag in Europe for the treatment of
anaemia in both dialysis and non-dialysis human patients. It is also used for
human
patients with anaemia from other causes, such as chemotherapy. Whilst
Eprex is a form of epoetin alfa, it is not identical to Epogen/Procrit.
See below for the
dosing protocol for Epogen, Procrit and Eprex and
how to obtain it
at a reasonable cost.
NeoRecormon
(epoetin beta)
Hoffmann LaRoche make a form of recombinant
human erythropoietin called NeoRecormon. This is epoetin beta, rather than epoetin alfa (Epogen, Eprex
or Procrit are epoetin alfa). It is becoming more common to use NeoRecormon in Europe for
cats with non-regenerative anaemia caused by CKD.
See below for the
dosing protocol for NeoRecormon and
how to obtain it
at a reasonable cost.
Aranesp (darbepoetin
alfa)
Amgen, the manufacturers of Epogen, also make
another type of ESA called
Aranesp (darbepoetin alfa). This
is slightly different to the other ESAs (Epogen, Procrit, Eprex and
NeoRecormon, all recombinant human erythropoietins or rhEpo), in that it
is an erythropoiesis stimulating protein which contains five N-linked
oligosaccharide (carbohydrate) chains rather than three. This is supposed
to give it greater metabolic stability, and may be why it is less likely
to cause the antibody reaction.
Darbepoetin alfa: a new therapy for the
management of anaemia associated with chronic kidney disease
(2002) Lindberg J Expert Opinion on Biological
Therapy
2(8) pp977-84 discusses the use of darbepoetin alfa in human patients.
See below for the
dosing protocol
for Aranesp and
how to obtain it
at a reasonable cost.
Which
Erythropoiesis Stimulating Agent
To Choose
The problem with the use of any human ESA in cats is that a small
percentage of cats develop an
antibody reaction
to the treatment. This is discussed below and is not as gruesome as
it sounds, but obviously it is something you want to avoid if at all
possible.
Epogen and Procrit (which is the same treatment with a
different name) have been used in CKD cats
in the USA for
many years. It was the subject
of a clinical trial in 1998,
Use of recombinant human erythropoietin for
management of anaemia in dogs and cats with renal failure
(1998) Cowgill LD, James KM, Levy JK,
Egrie JC, Browne JK, Miller A, Lobinger R: Journal of the American Veterinary
Medical Association
212 pp521-8), in which 30% of cats developed the antibody reaction.
Eprex has been used in CKD cats in the UK for many years - I myself used it
for Thomas in 1999 with no problems.
Janssen-Ortho, the
manufacturer, mentions that the
currently available HSA-free form of Eprex, which contains polysorbate 80 instead of albumin
in order to comply with European regulations, had a higher antibody
reaction rate.
Erythropoietin-associated PRCA: still an unsolved
mystery (2006) Schellekens H, Jiskoot W Journal of
Immunotoxicology 3(3) pp123-130 reports further on this issue.
I am not aware of any research into the use of NeoRecormon in cats, but my
UK vet now uses it routinely for CKD cats. I think if I had an anaemic
cat, I would probably favour it over Eprex these days.
Aranesp (darbepoetin
alfa) is becoming increasingly popular for use in cats because it appears less likely to
cause the antibody reaction. In 2005 a number of US
veterinary schools (including
North Carolina State University, University of Penn, Animal Medical Center
in New York, University of California at Davis, and the University of
California Veterinary Medical Center (UCVMC)) began using Aranesp on an
informal basis. The last four mentioned
institutions hope to publish the results of their experiences in the next
few years. University of Penn ran its own trial in 2010, and hopefully the
results of that study will be published in due course.
Aranesp has been used on approximately
50-60 cats at UCVMC, with favourable results. As a result, UCVMC now tends
to use Aranesp as a first line treatment for most cats (except when they
expect the need for an ESA to be short-lived because the cat is an acute
case, in which case they may use Epogen instead since it may show a
quicker response time). The Animal Medical Center in NYC also uses Aranesp
as a first line treatment, and has found the antibody rate to be around
10%.
Managing anemia in patients with chronic kidney
disease (2011) Chalhoub S, Langston CE Veterinary Medicine
May 2011 discusses
AMC's experiences with Aranesp.
There are two formulations of Aranesp, one
containing human albumin, and one with no albumin known as HSA-free. As
mentioned above, the HSA-free form
of Eprex had a higher antibody reaction rate. I do not know if this is also likely to be
true for Aranesp but it is a possibility. However, some vets feel that
ESAs
containing albumin may also carry an increased risk of an adverse
reaction, since the albumin is a human product. It now appears that
the only version which is widely available in the USA is the albumin free
(HSA-free)
version, because humans apparently had a lower reaction to this, so in
practice this is probably what you will be offered. I would not worry too
much about this.
Another factor to consider is which product your vet is comfortable
using. Some vets have never used ESAs, in which case it will be a learning
curve for both of you. But if your vet has a lot of experience using, say,
Epogen, you might feel more comfortable using that.
Overall, Aranesp is probably the best choice, certainly from the antibody
reaction perspective, and is the treatment of
choice at major US vet schools. There are a few
possible downsides to be aware of:
-
It costs a lot more than Epogen or Eprex. It needs to be given less
frequently, so the cost should even out over time, but the initial outlay
will be much higher, which is a concern for many people.
-
It may take longer to start taking effect. This can be a problem if your
cat's anaemia is particularly severe and you want to start making a
difference as quickly as you can.
-
It can be hard to work out the best dose for an individual cat. Some cats
respond too well to Aranesp, which carries risks too.
I think overall Aranesp is the best choice and is what I would choose
to use myself. However, if your cat has critically
severe anaemia, or if you can obtain one of the other ESAs more quickly,
then I would consider using that instead.
If you have already started another ESA but would like to switch to
Aranesp, read how to do this
here.
Treatment with Erythropoiesis Stimulating Agents
Dosage and usage
guidelines
What
to expect when using ESAs
Obtaining ESAs At Reasonable Cost
Some vets think ESAs costs hundreds of dollars, and therefore may not
bother to prescribe them. However, it is usually possible to obtain these products
for just a few dollars (or pounds) a dose if you know where to look.
USA
Aranesp
(darbepoetin alfa) - USA
Aranesp is more expensive than Epogen. It is sold as a
single use human medication but is routinely used in veterinary medicine
for multiple doses. You
need the 25mcg vial size which costs around US$150. This size vial contains
approximately feline 4-10 doses, depending upon the size of your cat and which
dosing regimen you use. However, since it does not need to be
administered as frequently as Epogen, the cost should work out about the same
overall. You will need a prescription from your vet.
You will usually also need U100 insulin 0.3 or
O.5cc syringes which you use to draw the Aranesp from the vial in cat-sized
doses. Brico
Medical sells 100 Terumo syringes for
around US$15 (you will need a prescription). You can also
obtain insulin syringes from your local pharmacy. The
Obtaining
Supplies Cheaply page has more information on
sources.
One person was initially quoted US$190 by
her local CVS for one vial of Aranesp in July 2011 but was able to negotiate this down to US$156.
In most cases though it is usually cheaper to buy Aranesp online.
Unfortunately, some online retailers seem
to sell a minimum of four vials, which cost over US$600. However, CVS and Safeway may be prepared to sell one vial for around
US$160 - 180. Walmart and Drugstore will definitely sell one vial at a
time (see below). You need Aranesp to be kept cold, so overnight shipping
is best.
Some of the pharmacies below offer family
savings plans whereby you pay an annual membership fee and then receive a
discount on the price of your prescription medications. These schemes
often permit cats to be enrolled as family members, which may further
reduce your costs. One member of my support group has printed out the free
Pet
Medication Card and has
successfully used it to obtain discounts at some pharmacies.
Pet Med
Saver Card and the
RX Free Card
also offer discounts, but I don't know anybody who has used them as yet.
It is usually easier to obtain price quotations if you have the NDC reference numbers for the products you are interested in.
The NDC reference number for a single vial of Aranesp is NDC 55513-002-01.
For a pack of four vials of Aranesp it is NDC 55513-002-04.
-
Walmart Specialty Pharmacy
sells Aranesp for around US$145 per 25mcg vial
including overnight refrigerated shipping. The website does not show prices so this is the
approximate price but a reader paid US$144.83 in April 2011 and a member of
Tanya's CRF Support Group
was quoted US$145 in September 2011. Note:
this is Walmart Specialty Pharmacy, which deals with complex
therapies such as ESAs. You must use the link above or the dedicated phone
number (1-877-453-4566) to get these prices, which are not available at
the standard online Walmart pharmacy and are unlikely to be available at
your local Walmart Pharmacy. It can take around a week to complete the
registration process the first time you order. Wal-Mart will contact you
to ask for your preferred delivery date, so you can be sure you are there
to receive it.
-
Drugstore
sells one vial of 25mcg Aranesp for US$155.98 or four vials for US$622.61 as at
September 2011. Overnight shipping costs an additional US$19.99. I have used Drugstore myself for other items and have
always received excellent service.
Epogen or
Procrit - USA
In the USA most people use the 2,000iu strength of Epogen.
This is a single use human medication but is routinely used
in veterinary medicine for multiple doses. You
do not want the 10,000iu and higher strengths, because it is too hard to
obtain cat-sized doses from these.
A
2,000iu strength vial will cost around
US28-$36, and depending upon your cat's weight this would usually be
enough for 5-8 doses.
You will usually also need U100 insulin 0.3 or
O.5cc syringes which you use to draw the Epogen from the vial in cat-sized
doses. Brico
Medical sells 100 Terumo syringes for
around US$15 (you will need a prescription). You can also
obtain insulin syringes from your local pharmacy. The
Obtaining
Supplies Cheaply page has more information on
sources.
Most people obtain their Epogen from an
online pharmacy (with a prescription), although you have to be very
careful about it being refrigerated during shipping.
Some of the pharmacies below offer family
savings plans whereby you pay an annual membership fee and then receive a
discount on the price of your prescription medications. These schemes
often permit cats to be enrolled as family members, which may further
reduce your costs. One member of my support group has printed out the free
Pet
Medication Card and has
successfully used it to obtain discounts at some pharmacies.
Pet Med
Saver Card and the
RX Free Card
also offer discounts, but I don't know anybody who has used them as yet.
-
Walmart Specialty Pharmacy
sells Epogen for around US$30 per
2,000iu vial (a vial will provide several treatments). The website does not show prices so this is the
approximate price but a member of
Tanya's CRF Support Group
was quoted US$30 in September 2011. Another
member paid US$98.17 in July 2011 for three vials of Epogen, syringes,
needles, a sharps container and overnight shipping. Note:
this is Walmart Specialty Pharmacy, which deals with complex
therapies such as ESAs. You must use the link above or the dedicated phone
number (1-877-453-4566) to get these prices, which are not available at
the standard online Walmart pharmacy and are unlikely to be available at
your local Walmart Pharmacy. It can take a few days to complete the
registration process the first time you order. Wal-Mart will contact you
to ask for your preferred delivery date, so you can be sure you are there
to receive it.
-
Walgreens
sells one vial of the 2,000iu strength for around US$39, or three vials
for a little less per vial). The website does not currently show prices so
this is the approximate price.
Walgreens
also sells six of the 2,000iu strength of Procrit
(same drug as Epogen) for around US200.
-
Family Meds
sells ten vials of the
2,000iu strength of Epogen for US$233.87, which works out at US$23.39 a
vial, but ten vials are a lot to buy at one time.
Family Meds
also sells six vials of the
2,000iu strength of Procrit (same drug as Epogen) for US$171.87, which
works out at US$28.65 a vial.
-
Drugstore
sells Epogen for US$38.31 per 2,000iu vial but there
is also a US$17 overnight delivery charge, so you might prefer to order
several vials at one time.
If you don't want to order online, some
local pharmacies in the USA, such as Walgreens, can order Epogen with
overnight delivery for around US$30-35 per 2,000iu vial. Hospital
pharmacies often have Epogen in stock and may well be prepared to sell it
to you with a prescription.
UK
Unfortunately
UK vets are now allowed to charge to write you a prescription to
use elsewhere. My vet charges £12.50. If
your vet does this, make sure your prescription is a repeat one so you
don't have to pay for a new prescription every month.
Aranesp -
UK
Aranesp is more expensive than Epogen. It is sold as a
single use human medication but is routinely used in veterinary medicine
for multiple doses. You
need the 25mcg vial size. This size vial contains
approximately feline 4-10 doses, depending upon the size of your cat and which
dosing regimen you use. However, since it does not need to be
administered as frequently as Epogen, the cost should work out about the same
overall. You will need a prescription from your vet.
Aranesp is
available in the UK. Your
vet should be able to order it for you, or give you a prescription so you
can obtain it from a local chemist. One member of
Tanya's CRF Support Group
bought it from her local chemist for
£105 for four vials, whilst another was
able to buy six vials for £141 from her vet, which included monthly iron
injections.
Eprex -
UK
This is a single use human medication but is routinely used
in veterinary medicine for multiple doses.
Eprex is available in various strengths but you do
not want the 10,000iu and higher strengths, because it is too hard to
obtain cat-sized doses from these.
You will usually be offered the 1,000iu
strength, which confusingly is the same as the 2,000iu strength, but half
the amount. Obviously, if you are using a lower strength, you need to give
more of it. Your vet should be able to advise you on which strength to
buy.
If your vet doesn't have it in stock, Eprex
is available from chemists, although you will need a prescription from
your vet, and the chemist may have to order it in for you (usually it can
be delivered in a day or two). Back in 2000 I bought mine from Boots. It costs around £100
for six 1000 iu syringes, which is the equivalent of 12-24 treatments for
most cats. In April 2011 Boots quoted me 12 vials of
1000iu/0.5mL Eprex for £107.51, but
needed five working days to get it. Lloyds Pharmacy told me they
could only get the 2000 strength, for around £100
for six vials, but didn't know the timeframe.
The best thing to do is to call pharmacies in your neighbourhood to check
prices and delivery timeframes. One lady wrote to tell me that she was able to obtain Eprex
very quickly from her local hospital pharmacy, with a prescription from
her vet, of course.
When we used Eprex, we did not need insulin
syringes; instead we used the syringe and needle in which the Eprex came,
giving half the vial each time. However, I am told that these days the
1,000 iu strength Eprex comes with safety syringes, which only work once.
Therefore, if you want to re-use the vial, you have to transfer the
contents into a sterile container, which is not exactly easy. The usual
method seems to be to
transfer the contents to an empty sterile vial, and measure it from there
with a small insulin syringe. Unfortunately this often means you end up
losing some of the Eprex, but it still works out cheaper than only using a
vial once.
NeoRecormon - UK
My vet's wholesaler (Dunlops) can get this for them quite quickly, so this
might be the quickest way to obtain it. In November 2011, one member of my
support group paid
£120 for six vials.
If your vet can't help, you would have to call around your local
pharmacies as outlined above for Eprex.
Canada
Aranesp- Canada
Aranesp is more expensive than Epogen. It is sold as a
single use human medication but is routinely used in veterinary medicine
for multiple doses. You
need the 25mcg vial size. This size vial contains
approximately feline 4-10 doses, depending upon the size of your cat and which
dosing regimen you use. However, since it does not need to be
administered as frequently as Epogen, the cost should work out about the same
overall. You will need a prescription from your vet.
-
Walmart in Canada sells
Aranesp. In November 2008 one person was quoted CA$133 for four vials of
the 25 mcg 0.4ml.
-
Benefit RX sells Aranesp for US$145.
I do not know anybody who has used them yet.
-
You could also ask your vet for a price.
Eprex- Canada
This is a single use human medication but is routinely used
in veterinary medicine for multiple doses.
In Canada, Eprex is available in various strengths but you do not want the
10,000 iu and higher strengths, because it is too hard to obtain cat-sized
doses from these.
You will usually be offered the 1,000 iu
strength, which confusingly is the same as the 2,000iu strength, but half
the amount. Obviously, if you are using a lower strength, you need to give
more of it. Your vet should be able to advise you on which strength to
buy.
When we used Eprex, we did not need insulin
syringes; instead we used the syringe and needle in which the Eprex came,
giving half the vial each time. However, I am told that these days the
1,000 iu strength Eprex comes with safety syringes, which only work once.
Therefore, if you want to re-use the vial, you have to transfer the
contents into a sterile container, which is not exactly easy. The usual
method seems to be to
transfer the contents to an empty sterile vial, and measure it from there
with a small insulin syringe. Unfortunately this often means you end up
losing some of the Eprex, but it still works out cheaper than only using a
vial once.
-
Walmart in Canada
sells six vials of 1000 iu strength Eprex for around CA$110.
-
Eprex should also be available from local
pharmacies, particularly hospital pharmacies. In November 2011, one
person in the Toronto area was able to obtain six vials
1000 iu strength Eprex from her local pharmacy
for CAN$119.
-
If you cannot find a Canadian supplier,
Entirely Pets in the USA sells Epogen for
US$45.99 for a vial of the 2000iu strength and will apparently ship to
Canada.
Australia and New Zealand
Although both Eprex and Aranesp are approved for human use in these
countries, unfortunately it can be hard to obtain human erythropoietin in
practice. This dates back to the Sydney Olympics, when the use of ESAs was
severely restricted in order to make it harder for athletes to abuse the
medication.
Aranesp - Australia
Aranesp is supplied in Australia by Amgen Australia Pty Ltd Level 7, 123
Epping Road, North Ryde. NSW 2113 Tel (02) 9870 1333.
Eprex- Australia
Your best bet is probably a hospital pharmacy, with a prescription from
your vet.
ESA Dosage and Usage Guidelines
Here are the basic guidelines to help you use your chosen ESA
as safely and effectively as possible.
How to Give
ESAs
These treatments are administered by
way of sub-cutaneous injection, so most people give the ESA to their cat
themselves at home. I used to give Thomas his ESA shot after his sub-Q
fluids, a short distance away from the sub-Q shot. ESAs may sting, although Thomas did not react too badly. You
will still have to visit the vet at regular intervals initially (once a
week), in
order to monitor PCV or HCT levels and blood pressure; but once the
cat is on a maintenance dose, less frequent checks are required (every
4-6 weeks).
These drugs contain no preservatives,
so MUST be kept in the refrigerator in between treatments, but since
the vials should not be shaken, do not keep them in the fridge door. It
is fine to leave the vial out at room temperature for 20-30 minutes
before administering it so it is not too cold when you inject your
cat.
You should not shake the vial, though
it is acceptable to roll it gently in your hand to warm it a little
before giving it to your cat.
Some pharmacists tell people they can
only use a vial once and then must throw it away; whilst this is true
of human patients, it is standard to re-use vials for cats, and I am
not aware of any problems arising from doing so, as long as the vial
is not past its "use by" date.
It is a wise idea to give any anaemic cat
B vitamins.
When you start giving an ESA, the cat's
body will try to produce a lot of red blood cells, but it needs
sufficient quantities of
iron
in order to complete
the process. It is therefore often recommended to use an
iron supplement as
well as the ESA in order to ensure that your cat has all the necessary
building blocks in place to enable the ESA to do its work. However,
iron can be constipating or cause stomach upsets, plus you may not need to give as much iron
as you would give if you were trying to correct a fullblown iron
deficiency, so some people find simply feeding a little liver (one or
two tablespoons, once or twice a week) provides sufficient iron with
less risk of constipation, and most cats seem to like the taste. You
should not give liver too often or in large quantities because it
contains very high levels of Vitamin A, but the above dosage should be
safe, but of course discuss this with your vet.
Managing anemia in patients with chronic kidney
disease (2011) Chalhoub S, Langston CE Veterinary Medicine
May 2011 has
information
about when and how to supplement iron when using ESAs.
Use of erythropoietin and calcitriol for chronic
renal failure in dogs and cats
(2005) Sanderson S
Presentation to the World Small Animal Veterinary Association World
Congress 2005 explains more about when and how to supplement iron when
using ESAs.
What to Expect When Using ESAs
Speed and Nature of Response
It usually takes around 1-2 weeks for
the medication to show an effect, with PCV or HCT usually rising
around 2% a week. Your vet should check PCV or HCT
and blood pressure a week
after starting treatment, and again a week later. Regular checks
should then continue until the level is stable. If you are giving the
ESA weekly, these checks may be performed weekly. If you are giving
the ESA less frequently, it is probably still wise to check PCV or HCT
and blood pressure weekly if you can, at least in the first month.
Some cats will show an abrupt increase in PCV in the first week of
use, perhaps as much as a 10% increase. This is more likely to happen
in cats with less
severe anaemia (and in fact some of
them perhaps are starting the medication a little prematurely, before
PCV or HCT is below 20%), and/or
in cats with less severe CKD (creatinine under 450 international, 5 in
US values) whose kidneys may still be able to make a little
erythropoietin on their own. One analogy used is that if a fire has
not gone out completely, it is easier to fire it up again than if it
has virtually gone out. An abrupt increase of this nature in the first
week is probably not cause for concern as long
as your cat's blood pressure is under control, but if PCV or HCT
continues to
rise faster than 4% in two weeks, you should ask your vet about
reducing the amount given, because rises in excess of this level have
been associated with an increased risk of hypertension and stroke in human
patients.
Conversely, some cats' PCV or HCT may continue to fall in the first
couple of weeks of use of an ESA. This is quite common if your cat is
dehydrated when you first begin the treatment.
As mentioned in
Hemoglobin and Hematocrit
(1990) Billett HH in Clinical methods: the history, physical
and laboratory examinations, Third Edition, Eds. Walker HK, Hall
WD & Hurst JW chapter 151, dehydration inflates the PCV or HCT
value, so if your cat is dehydrated when PCV or HCT is tested, the value
will appear higher than it actually is. For example, if your
cat has a PCV level of, say, 20%, but is dehydrated when the
test is run, the level may appear lower (say, 18%) once the
dehydration has been brought under control. The exact fall would
depend upon the level of dehydration at the first check.
If your cat is not dehydrated but PCV has fallen, it may simply be
that the medication needs a bit more time to kick in. I know when this
happens, some vets immediately say it is the antibody reaction, but
that is unlikely because the usual timeframe for the
antibody reaction is after 4-5 months of use.
Managing anemia in patients with chronic kidney
disease (2011) Chalhoub S, Langston CE Veterinary Medicine
May 2011
has a helpful table (in a pop up window halfway down the page)
entitled "algorithm to troubleshoot
persistent anemia (below PCV range) while using darbepoetin"
which your vet can use to as a checklist if PCV or HCT is not rising
as you would expect. Try not to panic. If you keep going,
double check you are giving the correct dosage, and your vet checks
for
other causes of anaemia, such as
gastro-intestinal bleeding
or infection, and ensures you are giving B vitamins and iron, you should start to see
an improvement after 2-3 weeks. In the meantime, depending upon how
severe your cat's anaemia is, you may have to consider a
blood
transfusion to tide your cat over until the ESA begins to work.
Very occasionally, it is possible to
stop giving ESAs completely. This might be the case, for example, with
a cat who has
acute renal failure
rather than CKD and whose anaemia improves as
the kidneys start functioning again. However, in a cat with CKD it is
unlikely that you will be able to stop the ESA completely, and
stopping and starting is not recommended (see
below).
Monitoring PCV or HCT Levels
During the first few weeks of using ESAs, PCV or HCT levels should be monitored carefully.
Initially it is best to check weekly, and since there is a
risk of hypertension when using ESAs, blood pressure
should be checked at the same time.
Always check PCV or HCT before
administering the next dose of the ESA, because you only want a rise
of around 2% a week (if it rises faster, it increases the risk of
hypertension and other problems). If it is rising faster than this, apart from in the
first week (see above),
then speak to your vet about reducing the dose you are using.
Target PCV or HCT Level
How high should the PCV or HCT be? This is a tricky question these
days, to which there is no simple answer.
When I first used an ESA in 1999, it was common to aim for a target
PCV or HCT of around 35% for cats on an ESA. This was roughly in the
middle of most laboratory ranges, and meant the cat was definitely no
longer anaemic (since many laboratory ranges start at 29%, while
others start at 24%). Going
above 35% was not recommended for cats because higher levels
increase the chances of thrombosis and
associated heart problems; but very few cats I heard about seemed to
have a problem with a PCV or HCT of 35%. This target also tied
in with the general recommendations for humans using ESAs.
For Aranesp, there is currently a wide range of
recommendations:
In June 2011 the FDA recommended that a goal for PCV or HCT
levels should no longer be set for human patients on ESAs (see
below). Instead, it
states that the lowest dose sufficient to "reduce the need" for blood
transfusions should be used.
It is possible that the various vet
schools may revise the higher targets for cats mentioned above in light of the FDA
recommendations for human ESA patients; but with cats
there are other factors to consider. Let's consider the Animal Medical Center recommendation
of a PCV or HCT of 25%.
With
some laboratories, this would actually mean that the cat was still anaemic or
barely out of anaemic range (the HCT range for some labs starts at 24%,
but at 29% for others), I believe this would be the case at AMC itself
- when my cat had blood tested there, the lab range began at
29%, although it is possible that the range has changed since then.
If your cat remains in the anaemic range, s/he might still be
experiencing the effects of anaemia.
A low target like this also gives you little room for manoeuvre should your cat
suddenly become more anaemic (perhaps because of sudden blood loss or
infection). It is relatively easy to arrange a
blood
transfusion for a human
whose anaemia suddenly worsens, with blood banks easily accessible almost
everywhere, but it is a lot harder (though not
always impossible) for a cat.
Therefore, in practice I think "reducing the need"
for blood transfusions would not be the best choice for most cats,
especially since there is a risk of an antibody reaction to repeated
blood transfusions in cats. Avoiding the need for transfusions seems more appropriate, especially for those who do not live in a
big city with prompt access to blood transfusions; and even those who
do live in such a place might wish to avoid the costs and
inconvenience and worry of a
transfusion.
You might
decide not to aim for an exact target, but to monitor your cat and alter
your ESA dosing once the HCT or PCV is approaching normal range and at
a stable level, as long as the symptoms of anaemia
have gone. If your cat is still showing signs of anaemia, however, you
may wish to cautiously aim for a higher PCV or HCT level. Generally
speaking,
a range of around 25-30%, depending
upon your laboratory's reference levels (25% if your laboratory's
range starts at 24%, or 30% if your laboratory's range starts at 29%), might be reasonable, but
aiming for 30-35%, as I have seen many people do successfully, might
also be appropriate, at least if your laboratory's range begins at 29%.
It's not easy, is it? When we made the
decision to use an ESA for Thomas, we decided to make sure he was no
longer anaemic. Despite all the increased knowledge about the use of ESAs
in cats today, I think I personally would still have the same goal today,
in which case I would aim for an HCT in the 30-35% range, but monitor
blood pressure carefully. Discuss with
your vet what would be most appropriate for your cat.
Frequency of Dosing
Once the PCV or HCT level is close to
your goal, the dose frequency is reduced
to whatever level is necessary to maintain the PCV or HCT at the
desired level.
With Aranesp, it is usual to reduce the
frequency from once a week to once every 2-3 weeks. Apparently many
cats only need a maintenance dose every 3-4 weeks.
With Epogen, Procrit, Eprex or
NeoRecormon, many vets reduce dosing frequency to twice a week
initially, but may then reduce to once a week or eventually to
once every 10-14 days. You may also be able to reduce the amount given
to as low as 75 units per kg bodyweight. If the anaemia
begins to recur at these lower levels or frequencies, you will usually
need to increase the amount and/or frequency of the injections (though
you should also check for other possible causes, such as infection or
gastro-intestinal bleeding).
There is a timelag of approximately 1-2 weeks
between giving the ESA and seeing its effects on PCV or HCT, so you
need to bear this in mind when adjusting dosages because PCV or HCT
levels will continue rising for some time after each dose.
Once a cat has reached a stable PCV or
HCT on an ESA, I would
recommend still checking PCV or HCT every 4-6 weeks in order to
ensure that your cat is not developing the
antibody reaction, and I would also get blood pressure checked at
the same time.
How to Check PCV or HCT
When testing PCV or HCT, it is not
necessary to draw a lot of blood (which could worsen the anaemia) - a
tiny drop taken from the ear may be sufficient. Veterinary
Partner has a description of how this is done in diabetic cats, as does
Sugar Cats.
Some
machines do need more blood than this, but it's worth asking your vet
if this method could be used because in most cases it can.
Several
members of
Tanya's CRF Support Group
use a
home hematocrit tester. It is
expensive (in August 2011 one person paid US$150 for the machine but
the total cost including accessories and shipping costs was US$195)
but over time it can pay for itself, and it is certainly less stress
than regular trips to the vet. If you wish to purchase one, try this
ebay link - he will ship worldwide.
If the link is broken (it changes regularly) the e-mail address at the
bottom of
this link is still valid, so
make contact that way. If you do buy a home tester, I would recommend
checking your first few readings against readings at the vet's, to
make sure you are doing it properly and to reassure your vet that you
are obtaining accurate readings at home. I'd also advise caution if
you are dealing with severe anaemia (PCV below
18%), because because when PCV is so low, every
percentage point matters, plus vet visits give your vet the
opportunity to check blood pressure as well
as checking PCV. If you do buy one of these machines, please check its
readings against those from your vet's equipment..
One possible compromise would be what one member of Tanya's CRF
Support Group used to do. He would obtain the blood from his cat's ear
at home as outlined above, but then take the sample to his vet for
analysis. This saved his cat the stress of the vet trip, but still
gave an accurate result.
Risks and Side Effects of ESAs
The antibody reaction is discussed
below, but
that is not normally seen (if it occurs at all) until the cat has been
on an ESA for 4-5 months. This section focuses on the risks
to be aware of as soon as you start using an ESA.
Most CKD cats do not seem to have
problems when using ESAs, but possible side effects include hair loss,
diarrhoea and very rarely seizures.
The major concern when
using an ESA is
hypertension, which in the worst case may cause heart
problems or a stroke.
The use of erythropoietin
(2003) Langston CE, Reine NJ & Kittrell D
Veterinary Clinics of North America Small Animal Practice
33(6) pp1245-1260 found that 40-50% of cats on ESAs develop hypertension, so
blood pressure should always be monitored while
your cat is on an ESA, particularly when you first begin treatment.
Since CKD cats are prone to
hypertension anyway, ideally you should have started monitoring blood pressure as
soon as your cat was diagnosed with CKD; but if you have not been
doing this, do try to ensure that blood pressure is monitored once you
begin the ESA. If your cat's blood
pressure rises to an unacceptable level (see
hypertension
for information on target blood pressure levels) and your cat is not
yet on blood pressure medication, you will probably need to start it. If you are already
giving blood pressure medication, you may need to increase the dose.
You may also need to decrease the amount and/or frequency of the ESA,
at least until blood pressure is under control. Be guided by your vet
as to the best course of action in your cat's case.
There is some debate as to whether
ACE inhibitors may exacerbate anaemia and/or induce some resistance to the use of human
erythropoietin in humans.
The role of ACE inhibitors and angiotensin II
receptor blockers in the response to epoetin (1999) MacDougall IC Nephrology Dialysis
Transplantion 14 (8) pp1836-1841 reports on the evidence for
and against this concern in humans. If your cat is on both an ESA and an ACE inhibitor such as Fortekor, I would discuss this
with your vet.
Dosage Guidelines
Dosage and Usage
Guidelines for Aranesp (darbopoetin alfa)
Please also read the general information on how to give ESAs and how to
monitor things above.
Aranesp Dosage
There are a number of possible dosing protocols
for Aranesp, so you must be guided by your vet as to which to use for your
cat. Remember,
Aranesp is given less frequently than Epogen, usually only once a week to
start with.
-
The dose for human patients on Aranesp is
0.45mcg per kg (a kg is 2.2 lb) body weight, given sub-cutaneously.
Plumb's Veterinary Drug Handbook
(6th edition) (2008) recommends this
dose for cats. This would mean that a 4.5kg (10 lb) cat would receive a
dose of just over 2mcg (see table below).
-
Dr S DiBartola of Ohio State University College of Veterinary Medicine
recommends a lower dose of 0.25 - 0.5 mcg per kg (a kg is
2.2 lb) body weight, given sub-cutaneously.
-
The current dosage being used by some
US veterinary schools, including the University of California at
Davis, is to give a single dose sub-cutaneously of 6.25 mcg each week,
regardless of the cat's weight. One vet school gives 6.25 mcg along
with iron in the first week, but then spaces it out as far as
possible, usually giving it once every 2-4 weeks. I have heard
from a number of people who found their cat's PCV increased too
quickly on this dose.
-
The Animal Medical Center in NYC uses a
dose of 1 mcg per kg bodyweight, so, for example, a 10lb or 4.5 kg cat
would receive 4.5mcg each week. Once target PCV is reached, both the
frequency and dosage are reduced to 0.45 mcg per kg body weight every
three weeks, but adjustments are made as appropriate for each cat.
-
I have also heard from a couple of people
who gave their cats
5 mcg sub-cutaneously each week. Again, one of these cats had a PCV
that was increasing rather quickly.
Because Aranesp is given less frequently
than rhEpo, it also takes longer to take effect. Therefore, if your cat
has very severe anaemia before starting Aranesp, you may need to consider
a
blood transfusion
to tide your cat over until the Aranesp begins to take effect.
Overall it appears that many cats respond well to Aranesp, and in some
cases their PCV rises too quickly. If your cat is not critically ill with
anaemia (e.g. the PCV is over 14%), I therefore recommend starting with a
low dose, particularly if your cat is
small. Always check PCV
before you give the next shot in case your cat is particularly
responsive.
Calculating
Your Cat's Dosage of Aranesp
|
If Dosage of 0.45 mcg per KG in Weight is Prescribed |
|
|
8 lb (3.65kg) Cat |
10 lb (4.5kg) Cat |
12 lb (5.45kg) Cat |
|
Aranesp Dosage |
1.64mcg |
2.03mcg |
2.45mcg |
If your cat's PCV rises too quickly (more
than a 2% increase in PCV or HCT per week), ask your vet about reducing
the dose or giving the Aranesp less frequently, because it is important to
adapt the dosing schedule to what works for your cat.
I heard from one person whose cat was being treated at a vet school that
one cat's HCT did not improve when the Aranesp was put into a vial
and dosed from there. However, when they emptied the pre-filled Aranesp
syringe into an insulin syringe and dosed directly from there, the cat's
HCT started rising. So it may be safer to dose in this manner.
Switching from Another ESA to Aranesp
Some people decide to switch from Epogen, Procrit or Eprex to Aranesp
because they wish to reduce the risk of the antibody reaction. This
section explains how do to this. However, if you wish to switch from
another ESA to Aranesp because you think your cat has developed the
antibody reaction to the other ESA, please read
here.
Be guided by your vet, but for reference,
Plumb's Veterinary Drug Handbook
(6th edition) (2008) states that
you can convert the dosage by dividing the total weekly number of Epogen
or Procrit units by 200. This will then give you the equivalent weekly
dose of Aranesp.
For example, if a cat receives 450 units of Epogen three times a week,
this means the weekly total is 1350. Divide the 1350 by 200 and you get
6.75, so the cat would receive 6.75mcg of Aranesp once a week.
In a presentation to the 2008 Western Veterinary Conference,
What's new pussycat? An update on feline renal
insufficiency) Dr Maggie Scherk
gives advice (bottom of Page 3) on how to calculate the dosage of Aranesp
if you are switching from Epogen to Aranesp, although her conversions
appear to be more generous than Plumb's (i.e. you would give more Aranesp
using her calculations).
Dosage and Usage
Guidelines for Epogen, Procrit or Eprex
Commonly
Used Dosages for Epogen, Procrit or Eprex
Plumb's Veterinary Drug Handbook
(6th edition) (2008) by Donald C Plumb suggests using 100 units of
Epogen, Procrit or Eprex per kg (2.2lbs) of bodyweight, given sub-cutaneously
three times a week, until you begin to approach the target PCV level
(usually around 35%).
Some cats may require higher doses
initially, particularly cats with severe anaemia. For cats whose PCV
or HCT is below 14%, Plumb's suggests
using up to 145 units per kg (2.2lbs) of bodyweight, also given sub-cutaneously
three times a week. You may also wish to discuss this dosage level
with your vet if your cat does not appear to respond to the treatment
at the initial starting dose outlined above.
However, a lower dose of 48.4
units per kg (2.2lbs) of cat, sub-cutaneously
three times a week, may be advisable if the cat has
hypertension (high
blood pressure) before starting Epogen, Procrit or Eprex, or if
hypertension appears after starting.
When giving the ESA three times a week, I would simply give it every
other day with one day left over e.g. Mon/Wed/Fri or Tue/Thur/Sat.
Calculating Your Cat's Dosage of Epogen, Procrit or Eprex
The exact amount to be given depends
upon the strength which you are using. These medications are sold in
varying strengths, but the larger sizes (10,000iu/mL upwards) are
impossible to give in cat-sized amounts, so try to use nothing larger
than the 3000iu/mL strength. Most people use the 2000iu/mL strength.
If for some reason you do end up using the 10,000 strength and above,
be aware that the medication may lose its potency before you get a
chance to finish the vial. This can lead you to incorrectly suspect
that your cat is developing the antibody reaction.
Calculating how much to use can be very
confusing! Normally you will be told how many units to give, based on
your cat's weight. 1 cc of the 3000iu/mL strength contains 3000 units
of medication; 1 cc of the 2000iu/mL strength contains 2000 units; and
so on. We used the 1000iu strength of Eprex, which (just to confuse matters) is
slightly different: it contains 1000iu but in 0.5mL so it is the same
strength as the 2000iu/mL although it sounds different. Whichever you
use is less important than giving the correct amount.
If you are using Epogen or Procrit, you
will probably also need syringes to give the medication. Most people
use human insulin syringes. These are sold as U100 syringes, which
means there are 100 units in 1 ml. They are usually available in three
sizes, 1 ml (100 units), 0.5ml (50 units) or 0.3 ml (30 units), and
most people use 0.5 or 0.3 ml syringes for cats (see
above for
sources). Unfortunately, insulin units are
not the same as Epogen units so working out the dose can be confusing.
As a general guide, one insulin unit is 0.01ml; so
each unit on an insulin syringe is 0.01ml; but the safest thing is to
ask your vet to measure out the doses for you and show you how much
you need to give.
As you can see, the Epogen dosages below are
pretty precise, but your vet will probably want to round the dose up
or down so as to make it easier for you to measure it. Although the
dosages refer to Epogen, they also apply to Procrit and Eprex.
|
If Dosage of 100 units per kg in Weight is Prescribed |
|
|
8 lb (3.65kg) Cat |
10 lb (4.5kg) Cat |
12 lb (5.45kg) Cat |
|
Epogen Strength |
Needs
365 Units
|
Needs
450 Units
|
Needs
545 Units |
|
1000 iu/mL*
|
0.1835 cc |
0.225 cc |
0.273 cc |
|
2000 iu/mL* |
0.1835 cc |
0.225 cc |
0.273 cc |
|
3000 iu/mL |
0.122 cc |
0.15 cc |
0.18 cc |
|
4000 iu/mL |
0.09 cc |
0.1125 cc |
0.137 cc |
*The 1000iu strength contains 1000iu
but in 0.5mL so it is the same strength as the 2000iu/mL
Please also read the basic
usage guidelines
for ESAs.
NeoRecormon
I have only heard from a few people using
NeoRecormon. Most people seem to be using it in similar fashion to Epogen
or Eprex, giving it three times a week and 50-100iu per kg of body
weight (usually 100iu per kg of bodyweight is used for Epogen or Eprex).
I did find one reference about using it,
Veterinary Pharmacology, which suggests
the above dose but which also recommends that PCV should increase by 1% a
day for the first month (!), which seems inappropriate to me - I would
recommend the more usual target increase of 2% a week would be a more suitable
goal.
Please also read the basic
usage guidelines
for ESAs.
Possible Problems with ESAs
There are two main reasons why some vets are reluctant to use ESAs.
-
The cost: vets often mistakenly believe that it costs
hundreds of dollars when in fact, depending upon your cat's size and the
severity of the anaemia, it may cost as little as US$5-10 per dose (see
Obtaining ESAs at Reasonable Prices).
-
They fear possible side effects as follows:
The
Antibody Reaction
What is the Antibody
Reaction
ESAs are extremely effective drugs, but
unfortunately, there is one potential major disadvantage to using them.
These medications are manufactured using recombinant human DNA. As a result, some cats
will eventually produce an antibody reaction because their
bodies consider the ESA to be a foreign body. These antibodies then neutralise
the ESA (i.e. stop it working to produce red blood cells), so the anaemia
returns. In this site I refer to this as the antibody reaction, but
elsewhere you may see this referred to as
PRCA, which is the most extreme
form of the antibody reaction.
Because of the risk of the antibody reaction, it is usually recommended
that cats should not be placed on ESAs until the benefits of using them outweigh the risks.
For most cats this means once their PCV
has fallen to 15-19% and they are showing symptoms of anaemia, such as
loss of appetite, lethargy etc. In theory, this will often not happen
until the CKD is fairly well advanced with creatinine levels over 500 (US:
5.65), although this is not always the case - Thomas needed rhEpo
regularly when his creatinine level was only 316 (US: 3.57), although this
had been a lot higher at initial diagnosis.
It is not known for certain how many cats go on to
develop this antibody reaction because it is hard to test for this. Some sites refer to a rate of around 70%
but in the only clinical trial to date on the use of an ESA in cats,
Use of recombinant human erythropoietin for
management of anaemia in dogs and cats with renal failure (1998) Cowgill LD, James KM, Levy JK,
Egrie JC, Browne JK, Miller A, Lobinger R: Journal of the American Veterinary
Medical Association
212 pp521-8), the number of cats who developed
the reaction to Epogen was around 30%. In
Anemia of chronic kidney disease (2009)
Dr CL Langston says that the rate seen at Animal Medical Center in NYC is
around 21% for Epogen.
It appears that Aranesp may be less likely
to cause the antibody reaction. There has been one suspected case of the
antibody reaction in a dog at UCMVC but this was never confirmed. I
haven't heard of any confirmed cases in cats as at October 2011, though
they probably exist. In
Anemia of chronic kidney disease (2009)
Dr CL Langston says that the rate seen at Animal Medical Center in NYC is
around 10% for Aranesp, but this figure includes dogs (they have had two
confirmed cases in dogs) and I don't know how much of that percentage were
cats.
In my experience over the last ten
years of monitoring a number of CKD-related online groups, the frequency
of the antibody reaction in practice appears to be far lower than 25-30%,
perhaps closer to 5-10%. See
below for a possible explanation of this discrepancy.
It is impossible to predict which cats will develop
the antibody reaction, although Eprex appears to carry a higher
risk of the antibody reaction for humans than either Epogen or Procrit,
particularly if the HSA-free form of Eprex (which contains polysorbate 80
instead of albumin, in order to comply with European requirements) is
used. There is more information about this from
Janssen-Ortho, the
manufacturers of Eprex.
Erythropoietin-associated PRCA: still an unsolved
mystery
(2006) Schellekens H, Jiskoot W Journal of
Immunotoxicology 3(3) pp123-130 reports further on this issue.
The antibody reaction does not usually occur in the
first month of use, and if it is going to occur it almost always happens
around 4-5 months after commencing treatment (only rarely does it happen
much earlier or later than this). There is no definitive test to show that
the cat has developed the antibody reaction; a bone marrow aspiration
(biopsy)
would provide some information, but is invasive and unlikely to be
worthwhile.
Pet Place explains more about bone marrow
and bone marrow biopsy.
Washington State University College of Veterinary
Medicine has some information on how this procedure
is performed.
From a practical perspective, the main sign of an antibody reaction
is that the cat's PCV value will steadily drop by approximately 2% a week,
despite the use of adequate amounts of an ESA. Large drops in PCV in the
space of a few days or a week are unlikely to be caused by the antibody
reaction, and other
possible causes
such as
gastro-intestinal bleeding should be investigated. Rapid falls may
ocassionally be
a sign of
PRCA, but this is
rare.
To complicate matters further, your cat may
actually need more ESA than you have been giving: many vets give a too
small dose in the mistaken belief that this may reduce the risk of the
antibody reaction. Plus some cats simply need more ESA than others -
Thomas's PCV went up and down in the first few weeks of treatment so we
were very worried, but we simply gave him more of the ESA rather than
less, and his PCV then rose steadily. A cat whose CKD is advancing may
also need more ESA than s/he previously needed. A cat who appears not to
be responding to the ESA may also need more iron. If for some reason you
are using the 10,000 strength and above (which is not recommended in
cats), the drug may lose its potency before you get a chance to finish the
vial. This can lead you to incorrectly suspect that your cat is developing
the antibody reaction.
Other possible causes for a failure to respond to ESAs include a lack of
folic acid
(Vitamin B9) or Vitamin B12, infection, inflammation, cancer or hidden
blood loss (e.g from gastro-intestinal bleeding).
So if PCV levels do begin to fall, you
should not automatically fear the worst, but instead should consider all
other possible causes of the fall. In
Anemia of chronic kidney disease
(2009)
Langston CL says that over 75% of
human patients whose anaemia does not improve on an ESA have an infection
or inflammation. She states "In a retrospective study of cats, 25 per cent
of patients did not reach the target hematocrit and were suspected of
having infection or inflammation (unpublished data, Langston and Kittrell,
2006). Higher doses of rHuEPO do not overcome the resistance; control of
the infection or inflammatory state is necessary."
Why the Risk
of Using an ESA is Often Worth It
Whilst nobody wants their cat to experience the
antibody reaction, it must be stressed that it is not as awful as it
sounds. Some people think it is akin to anaphylactic shock but it is
nothing like that at all!
What normally happens is that the PCV gradually falls at
a rate of around 2% a week (any larger fall and you should search for another
cause, such as
gastro-intestinal bleeding), despite the cat
being on an ESA. If the cat
is still producing a little erythropoietin naturally, the antibodies may
also neutralise the cat's own erythropoietin as well, at least for a
while, and this further worsens the anemia. In the worst case, a
condition called
PRCA can occur.
But, and most importantly, even in those
cats who develop the antibody reaction, the erythropoietin antibodies will
not always neutralise the effects of the ESA. In other words, some cats
may have the antibody reaction but you would never know it because the ESA
continues to work and the cat does not become anaemic again. This may
explain why it is often claimed that 30% of cats develop the antibody
reaction, yet in practice on the online support groups, the percentage
appears to be much lower, around 5-10%.
If your cat
does develop the antibody reaction to an ESA, since
the resulting anaemia will eventually kill the cat, the only remedy is to
stop using the ESA. It takes the cat's body 3-4 months until the
antibodies wear off, and during that period it is often necessary to keep
the anaemia under control via
blood
transfusions. You cannot start using the ESA again, even after the
antibodies wear off, so depending upon the level at which your cat's
anaemia stabilises, you may need to use blood transfusions indefinitely.
Some vet schools have been investigating using Aranesp in cats who have
developed an antibody reaction to Epogen or Eprex, you can read more about
this
here.
In most cases the cat was suffering from severe anaemia,
otherwise an ESA would not have been started in the first place. So in the
worst case, using an ESA will have bought you an extra few months with
your cat; and in the best case, using an ESA could control your cat's
anaemia indefinitely.
Why Stopping and Starting ESAs is a Bad Idea
Very occasionally, it is possible to
stop giving ESAs completely. In fact, if your cat has
acute renal
failure rather than CKD, you may not need to start them in the
first place - although cats with ARF tend to have high bloodwork
results generally, they often are not anaemic, or, if they are, the
anaemia resolves itself naturally as the kidneys begin working again.
However, I have heard that some vets
have a policy for every CKD cat they treat of using an ESA short-term
until the anaemia is resolved, then stopping it and starting it again
later when the cat has become anaemic again, in the mistaken belief
that this may reduce the risk of the antibody reaction.
This is really not a good idea. Dr
Katherine James, who participated in the Epogen trial in cats
mentioned
above (the
trial that has many vets worried about the antibody reaction in the
first place) has stated that there is no evidence either way, but she
suspects that doing this might actually increase the risk of the
antibody reaction occurring. She also believes that the resulting
fluctuations in PCV could cause problems with blood pressure control.
On the most basic level, I really do
not see the point of allowing a cat to become anaemic again, with all
the strains on the body and effects on the cat's quality of life which
that entails. Most scarily, I have heard from two people whose vets insisted
on this approach and their cats died of anaemia during one of their
anaemic phases. If you decide to use an ESA, I'd recommend making a
commitment to using it fully in order to keep your cat free
of anaemia.
Pure Red Cell Aplasia (PRCA)
In the worst case, the antibodies to an ESA which some cats develop may cause the cat
not only to neutralise his or her own erythropoietin but also to
develop a condition called pure red cell aplasia (PRCA), which
also kills off existing red blood cells. In such a case, the cat develops a sudden
loss of response to the ESA, the PCV or HCT level falls suddenly, and the reticulocyte
count will be extremely low. The cat will often be very lethargic and
short of breath.
Many vets believe that the antibody reaction to ESAs is identical to PRCA.
They therefore fear that the chance of this happening is around 30%,
and consider that any cat who suddenly becomes more anaemic despite being
on an ESA must be developing PRCA.
I see it more
as a question of degree. Whereas
some cats develop the antibody reaction mildly (so the ESA keeps on
working for them, see
above), those cats who develop
PRCA are exhibiting a reaction at the opposite end of the spectrum, which
also affects their existing red blood cells. In
Pure red cell aplasia clinical presentation
(2009), Dr Paul Schick states that "The development of pure red cell aplasia may represent the extreme end of the spectrum of EPO-induced
immunological suppression of RBC production."
PRCA is
thought to be an
autoimmune condition, and developing it as a result of using an ESA is rare - humans
on ESAs have a rate of PRCA of less than 1%. Most cases in humans on ESAs
occurred in people using Eprex prior to 2003, and cases tended to be
concentrated within certain countries such as the UK and France, whereas
Germany had hardly any. The cases that were seen coincided with a change
to the formulation of Eprex.
Janssen-Ortho, the
manufacturers of Eprex, state that the
currently available HSA-free form of Eprex, which contains polysorbate 80 instead of albumin
in order to comply with European regulations, had a higher PRCA rate; and
it was also thought that the way the drug was administered may have been a
factor (sub-cutaneous administration appeared to increase the risk).
Erythropoietin-associated PRCA: still an unsolved
mystery (2006) Schellekens H, Jiskoot W Journal of
Immunotoxicology 3(3) pp123-130 reports further on this issue.
Following prescribing changes in December 2002, even though the same type
of Eprex was being used, the number of human
cases of PRCA fell dramatically.
PRCA appears to be more common in cats, though it is hard to know exactly
how many cats develop it because many vets do not differentiate between
PRCA and the less severe form of antibody reaction. In humans, PRCA
usually does not occur until the patient has been on an ESA for three
months. If the same applies to cats, you should therefore be safe for the
first three months of using an ESA. If your cat's PCV or HCT suddenly
falls, whether during or after the first three months of use, consider
other causes before fearing the worst. In
Anemia of chronic kidney disease
(2009)
Dr CL Langston says that over 75%
of human patients whose anaemia does not improve on an ESA have an
infection or inflammation. She states "In a retrospective study of cats,
25 per cent of patients did not reach the target hematocrit and were
suspected of having infection or inflammation (unpublished data, Langston
and Kittrell, 2006). Higher doses of rHuEPO do not overcome the
resistance; control of the infection or inflammatory state is necessary."
Therefore, if your cat's PCV
falls suddenly, you should not necessarily immediately stop the ESA but
you should look for other causes of the fall such as infection, Vitamin B12
deficiency etc.
If, however,
your cat really does develop the antibody reaction so severely that PRCA
results, you must immediately stop using
the ESA. You might need to arrange a
blood
transfusion
for your cat. It takes the cat's body 8-10 months until the
antibodies wear off, and during that period it is often necessary to keep
the anaemia under control via regular blood transfusions. You cannot start using the ESA again, so depending upon the level at which your cat's
anaemia stabilises, you may need to use blood transfusions indefinitely.
Although this is a big commitment and expense, I do know of people who
have
done this successfully. Some vet schools have been investigating using Aranesp in cats who have
developed an antibody reaction to Epogen or Eprex, you can read more about
this
here.
Please don't
feel guilty if your cat develops PRCA. Your
cat was most probably suffering from severe anaemia, otherwise an ESA
would not have been started in the first place. So in the worst case,
using an ESA will have bought you an extra few months with your cat; and
in the best case, using an ESA could control your cat's anaemia
indefinitely.
FDA Warnings
As mentioned above, there can be
other risks using ESAs,
such as high blood pressure, seizures,
heart problems and strokes (although controlling blood pressure does help
reduce the risk of many of these issues).
Various warnings relating to these concerns
have been issued by the US Food & Drug Administration over the years regarding the use of ESAs in humans.
The 2007 warning
recommended aiming
for lower target haemoglobin levels than many doctors originally aimed
for, because this reduced the risks of serious side effects. Previously
many doctors aimed for a haemoglobin (Hb) level over 12, but the 2007 warning
recommended aiming for an Hb level of between 10 and 12.
Targets for human ESA patients are measured
in haemoglobin, but in haematocrit (HCT) or
packed cell volume (PCV) for cats. To convert Hb into HCT, you multiply by
approximately three. If the advice for humans was extrapolated to cats, this would
have meant that your target HCT (based on the maximum Hb level of 12) should be no higher than 36. Since it had long been recommended that people aim for a conservative HCT or PCV
level of no more than 35% in cats using these products, this
warning did not raise any additional concerns when it was issued.
The 2011 warning,
issued in June 2011, states that humans on ESAs are
considered to be at greater risk of adverse events if they target an Hb
level of 11. The FDA now declines to state when humans should start ESAs or
what level of Hb they should aim for, but instead recommends individualised
dosing and states that the lowest dose sufficient to reduce the
need for blood transfusions should be used.
I discuss the implications of these warnings for cats
above.
Should I Use an ESA?
I know it is not easy
making the decision to use an ESA, and your head is probably spinning
after reading this page (I've tried to make it as clear and simple as I
can, but I'm afraid it's a complicated subject). Please discuss the pros
and cons with your vet before making your decision. Remember, you should
not normally need to use an ESA if the cat's PCV or HCT is 20% or higher.
The criteria for knowing if it is time to consider using an ESA are
here.
If your cat does have severe CKD-related anaemia caused by a lack of
erythropoietin, then to some extent there
is no real decision to make, because the only real alternative to starting an ESA is to watch your cat die of
anaemia. We decided to
use an ESA for the following reasons:
-
It was quite obvious that if we did not do
so, the anaemia would kill Thomas long before the CKD would (he was
extremely weak, had no appetite and was breathless).
-
We felt the odds were in our favour with at least a
two to one chance that it would work for us.
-
Even if he were to develop the antibody
reaction, it should buy him 4-5 months of additional time and thus
postpone having to say goodbye.
-
In the best possible scenario, once the ESA had done its work, we would
never have to worry about CKD-related anaemia caused by a lack of
erythropoietin again.
If you are considering the use of an ESA,
don't take too long to make your decision, because if you do, your cat may
die of the anaemia before the ESA has a chance to take effect (it may take
up to two weeks to see an improvement after starting to use an ESA, and
the anaemia should only improve gradually). If your cat has a low PCV or
HCT but is acting relatively well, don't be lulled into a false sense of
security. Because non-regenerative anaemia caused by CKD tends to develop
and worsen gradually many cats' bodies do adapt to the anaemia, so they
may not seem desperately ill but they could still suddenly hit crisis
point. If necessary, a
blood transfusion
might help your cat through a critical period while
you wait for the ESA to take effect.
Personally I would never let PCV fall below
15% before starting an ESA, and if my cat was showing symptoms of anaemia
with a PCV of 16-19%, I would start it earlier. We began it as soon as
Thomas was diagnosed following his crash, when his PCV was 18% (though it
was probably lower, since he was severely dehydrated at the time -
as mentioned in
Hemoglobin and Hematocrit
(1990)
Billett HH in Clinical methods: the history, physical and laboratory
examinations, Third Edition, Eds. Walker HK, Hall WD & Hurst JW
chapter 151, dehydration makes PCV look higher than it really is). When he
died seven months later, his anaemia was completely under control. If we
had not used the ESA, he would have only managed a month at most.
So, to summarise:
-
at the present time there are no alternatives to ESAs
for the treatment of severe CKD-related non-regenerative anaemia (milder
anaemia may be treated via the methods outlined
here).
-
if you do not use an ESA for severe CKD-related
non-regenerative anaemia, your cat will die of anaemia.
-
the antibody reaction is rare. Even going by the worst case statistics, your cat has less
than a 1 in 3 chance of developing the antibody reaction whilst on Epogen,
or only a 10% chance while on Aranesp. That's a 90% chance in your favour! Based on what
I've seen over twelve years of online support groups, your cat has more like
a 1 in 10 to 1 in 20 chance of developing the antibody reaction.
-
if your cat does develop the antibody
reaction, it will not usually be for 4-5 months, during which time your
cat will have no problems at all with anaemia.
-
if the antibody reaction occurs, your cat will gradually become anaemic
again, which simply means you will be back where you started 4-5 months
earlier when you first decided to use erythropoietin.
-
if the antibody reaction occurs, you will
see a fall in PCV/HCT of around 2% a week. A larger fall may indicate
PRCA, but may also indicate
some other cause, such as
gastro-intestinal bleeding.
-
if your cat develops the antibody reaction, you will probably have to use
blood transfusions
to control the anaemia instead. At the present time I know of no other
treatment, except possibly switching to
Aranesp
if you are currently using another ESA.
-
if your cat, as is most likely, does not develop the antibody reaction,
s/he will have no problems with anaemia and all its attendant side effects
in the future.
Ultimately it is your decision whether to use an ESA.
There have been trials into feline alternatives (see
below) but, according to
the researchers involved, none of these studies is
expected to result in the commercial availability of alternative
treatments in the foreseeable future.
If you do decide to use an ESA, Aranesp (darbeopoetin
alfa) is probably the best choice, and is what I would try to use if I
needed to use one for my cat.
Using
Aranesp in Cats Who Have Developed the Antibody Reaction to Epogen,
Procrit or Eprex
It is not recommended to use any form of
ESA in a patient who has reacted to another form (in other words, if you
have developed the antibody reaction to Epogen, it is not advisable to use
Aranesp instead). Since there are some differences between Epogen and
Aranesp, some US vet schools have tried to maintain cats who have
developed the antibody reaction to Epogen or Eprex by using blood
transfusions for several (6-8) weeks, and then starting them on Aranesp,
in the hope that the cats will not also develop an antibody reaction to
Aranesp. Apparently there is anecdotal evidence that this approach worked
for one cat but it did not work for any others. Sometimes prednisone, a
steroid, is
used in the interim period before starting treatment with Aranesp.
One person whose cat may have developed the
antibody reaction to Epogen (this person's vet had recommended a
stop/start approach,
which is not advisable because it may increase the risk of the antibody
reaction) tried to switch to Aranesp. He found that using Aranesp alone or
Aranesp and prednisone did not help his cat, but using it in conjunction
with both
prednisone and chlorambucil (Leukeran), an immunosuppressive drug
commonly used in the treatment of cancer, did help for a while. This
regimen was based on the successful treatment plan for a woman who also
developed the antibody reaction. However, Leukeran can itself cause
anaemia.
Pure red cell aplasia secondary to epoetin alfa
responding to darbepoetin alfa in a patient on peritoneal dialysis
(2004) Asari A R Gokal R Journal of the American Society of Nephrology
15 pp2202-7 reports on the case of a human patient who developed
the antibody reaction to Epogen who was successfully switched to Aranesp.
Successful reintroduction of a different
erythropoiesis stimulating agent after pure red blood cell aplasia:
relapse after successful therapy with prednisone (2005) Andrade
J, Taylor PA, Love JM, Levin A Nephrology Dialysis Transplantation
20 pp2548-51 discusses the case of a woman who developed the
antibody reaction and who was helped by prednisone.
Erythropoietin, cure or nightmare
Chan SK, Chan CK, Chow CC (2004) is a presentation to the Hong
Kong Society of Nephrology Interhospital Meeting about a woman who
developed the antibody reaction and who was helped by prednisone and
chlorambucil.
Mar Vista Vet
has some information about
chlorambucil (Leukeran).
Feline Erythropoiesis
Treatments
Feline
Erythropoietin (rfEpo)
Feline Erythropoietin
Gene
Feline Erythropoietin (rfEpo)
Feline erythropoietin is not commercially available currently, but was
developed in small quantities for use in two feline trials, one in 2010 at
Colorado State University and one in 2002 at Cornell.
Feline
Erythropoietin Trial (2010)
The sponsor of this study at the Veterinary
Teaching Hospital at Colorado State University engineered a
new feline erythropoietin (rfEpo). In 2010 this was administered to
18 healthy cats at varying doses and on average, raised the red blood cell
count 25% or more with no side-effects and the effect lasted more than one
month.
Cornell Feline Erythropoietin Trial (2002)
A new synthetic form of feline
erythropoietin was developed at Cornell University in the USA, and a
one year trial for CKD cats was completed there in November 2002.
Expression,
bioactivity and clinical assessment of recombinant feline erythropoietin (2004) Randolph JF, Scarlett JM, Stokol T, Saunders
KM and McLeod JN American Journal of Veterinary Research 65 (10)
pp 1311-1450 explains the outcome of the study. Unfortunately, whilst the
rfEpo was effective at curing anaemia in the study cats, even in those
cats who had previously had an antibody reaction to human erythropoietin,
26% of the cats receiving feline erythropoietin (and who had never used
human erythropoietin) developed an antibody reaction to the feline
erythropoietin.
Feline Erythropoietin Gene Studies
2011 University of California at Davis
The Winn Feline Foundation reports on a
2011 grant to the University of California at Davis College of Veterinary
Medicine to create a feline erythropoietin gene, with a view to using this
later in clinical trials.
2000 Ohio State University
A 2000 study at
Ohio State University College of Veterinary Medicine investigated the development of
a feline erythropoietin gene. The gene that
makes feline erythropoietin was implanted into the leg or back muscle by an intramuscular injection similar to a vaccination.
Tests conducted on healthy cats showed that this increased PCV levels over
a seven week period following the injection.
Results were mixed with some cats responding extremely well and others
less well, but overall the trials were encouraging. Once the gene is
implanted, the cat should produce erythropoietin on its own, and in the
trials responsive cats had been doing so for up to one year. Further
trials may be conducted in due course.
Transfer of the feline erythropoietin gene to cats
using a recombinant adeno-associated virus vector
(2000) Beall
CJ, Phipps AJ, Mathes LE, Stromberg P, Johnson PR Gene Therapy 7
(6) pp 534-539 describes the beginning of the trial.
Prevention Magazine has brief information on the trial - scroll down to
the section entitled "New hope for old cats".
Back to Page
Index
This page last updated: 17
October 2011
Links on this page last
checked: 18 August 2010
|